BetterLife Pharma BETRF
OTC BETRF
$0.18 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

BetterLife Pharma (BETRF) Non-Current Deffered Revenue (2021 - 2026)

Updated

BetterLife Pharma's Non-Current Deffered Revenue came in at $305,404 for fiscal Q2 2027 (quarter ended Jul 31, 2026), up 9.7% from $278,325 a year earlier but down 0.2% from the prior quarter.

Analysis

BetterLife Pharma (BETRF) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends

At the end of FY2026 (ended Jan 31, 2026), BetterLife Pharma's Non-Current Deffered Revenue was $296,536, up 6.8% from FY2025.

  • Non-Current Deffered Revenue carries a five-year compound annual growth rate of 16.8% (FY2021 to FY2026).
  • Going back by fiscal year, Non-Current Deffered Revenue was $277,690 in FY2025 (-31.9%), $408,024 in FY2024 (-20.1%), $510,440 in FY2023 (-29.1%) and $719,448 in FY2022 (+427.8%).
  • The five-year range for quarterly Non-Current Deffered Revenue is $17,732 (fiscal Q4 2023) to $711,939 (fiscal Q4 2022).
  • Year-over-year, Non-Current Deffered Revenue has increased for three consecutive quarters, with growth averaging 156.5% over the last six quarters.
  • The fastest year-over-year change in Non-Current Deffered Revenue over five years came in fiscal Q4 2025 (growth of 969.5%), and the weakest in fiscal Q4 2023 (a decline of 97.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 BetterLife Pharma 27.34 Mn 28.95 Mn - 303,919.74
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 303,919.74
Apr 30, 2026 306,730.88
Jan 31, 2026 305,999.10
Jul 31, 2025 276,616.62
Apr 30, 2025 276,584.59
Jan 31, 2025 263,870.83
Oct 31, 2024 274,969.81
Jul 31, 2024 397,406.42
Apr 30, 2024 402,724.88
Jan 31, 2024 25,407.22
Jul 31, 2023 675,029.09
Apr 30, 2023 508,648.75
Jan 31, 2023 17,870.11
Oct 31, 2022 490,180.10
Jul 31, 2022 511,196.22
Apr 30, 2022 300,891.86
Jan 31, 2022 706,237.12
Oct 31, 2021 46,195.97
Jul 31, 2021 163,155.36
Apr 30, 2021 148,417.26
API Access

BetterLife Pharma Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BETRF&period=max&api_key=YOUR_API_KEY